Authorized Sale of a Product Does Not Exhaust Patent Rights Against Upstream Parties in the Chain of Commerce

Apr 4, 2019

Reading Time : 2 min

Perfect ultimately settled with Apple, agreeing not to sue Apple or Apple’s customers for infringement of the asserted patents. That settlement included a carve out excluding from the agreement Perfect’s infringement claims against Adaptics. Adaptics filed a motion for summary judgment alleging that, despite the carve out, Perfect’s settlement with Apple exhausted Perfect’s patent rights in the accused products. If it did not, Perfect could recover twice on the value of its patent. Perfect disagreed, arguing that patent exhaustion only applies to subsequent, downstream purchasers after an initial authorized sale; it does not apply to upstream manufacturers.

The court agreed with Perfect, holding that “because patent exhaustion only applies to the patentee’s rights against downstream transfers, Perfect’s settlement with Apple did not exhaust its rights against Adaptics.” The court characterized Adaptics’ argument as requiring “a novel, upstream-oriented application of patent exhaustion that has no support in case law.” In reaching this conclusion, the court first walked through the Supreme Court’s recent Impression Products, Inc. v. Lexmark International, Inc., 137 S. Ct. 1523, 1532-33 (2017) decision relating to patent exhaustion. The court noted that Adaptics is likely correct that the settlement authorized Apple and all of Apple’s customers to sell products manufactured by Adaptics, exhausting Perfect’s rights against Apple and Apple’s customers. But that was irrelevant to Perfect’s rights against Adaptics itself because Impression Products related to the rights of subsequent owners to use or resell a product. And the other district court cases that considered Adaptics’ upstream patent exhaustion arguments had similarly rejected them.

The court then addressed Adaptics’ argument that Perfect would be recovering twice for the same infringement. The court rejected this theory as well, explaining that Adaptics’ and Apple’s alleged infringement was not the same act of infringement. According to the court, Adaptics’ infringement necessarily occurred before any authorized sales by Apple. And, in any event, when a patentee settles with a downstream distributor, both parties are necessarily aware of the existence of the infringing manufacturer and presumably account for that by limiting the settlement to less than the patent’s full value. Thus, there was no danger that Perfect was recovering twice for the same infringement.

Practice Tip: When negotiating a settlement or developing a reasonable royalty damages theory, parties should always account for the existence of both upstream and downstream links in the chain of commerce. In this case, Apple apparently determined that carving out Adaptics’ conduct from the settlement agreement was in its interest. The lack of upstream patent exhaustion, as the court observed, would tend to support a lower royalty or settlement amount for the reseller. But in other cases, it may be in the reseller’s interest to include the upstream manufacturer in the settlement to insure a continued supply of the accused product.

Perfect Co. v. Adaptics Ltd., 14-cv-3714-RBL (W.D. Was. Mar. 19, 2019) (Dkt. No. 425)

Share This Insight

Previous Entries

IP Newsflash

April 1, 2025

The District of Delaware recently denied in part a motion to compel production of documents and testimony between a patentee and potential investors, valuation firms and an international bank based on the common interest exception. In so doing, the court reaffirmed that disclosure of privileged information to third parties will generally waive privilege unless it can be shown that the parties’ interests are identical and the communications are legal, not solely commercial.

...

Read More

IP Newsflash

March 24, 2025

The Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) final written decision holding that the prior art exception of AIA Section 102(b)(2)(B) does not apply to a prior sale by an inventor when the sale is conducted in private. According to the Federal Circuit, a sale must disclose the relevant aspects of the invention to the public to qualify for the prior art exception of Section 102(b)(2)(B).

...

Read More

IP Newsflash

March 21, 2025

Under the Lanham Act, a plaintiff who prevails on a trademark infringement claim may be entitled to recover the “defendant’s profits” as damages. The Supreme Court in Dewberry Group, Inc. v. Dewberry Engineers Inc. unanimously construed “defendant’s profits” in 35 USC § 1117(a) to mean that only the named defendant’s profits can be awarded, not the profits of other related corporate entities. The Court, however, left open the possibility that other language in § 1117(a) may allow for damages linked to the profits of related entities, if properly raised and supported.

...

Read More

IP Newsflash

March 13, 2025

In a series of rulings on a motion in limine, the District of Delaware recently distinguished between what qualifies as being incorporated by reference and what does not for the purposes of an anticipation defense. In short, a parenthetical citation was held to be insufficient, while three passages discussing a cited reference met the test.

...

Read More

IP Newsflash

March 4, 2025

On February 28, 2025, the USPTO announced that it was rescinding former Director Vidal’s 2022 memorandum on discretionary denials by the Patent Trial and Appeal Board. The 2022 memorandum effectively narrowed the application of discretionary denials in cases with parallel district court litigation by specifying instances where discretionary denial could not be issued. With the withdrawal of the memorandum, individual PTAB panels will regain flexibility in weighing discretionary denials. While the long-term effect of that increased flexibility is not yet known, the immediate effect is likely to be a shift towards the discretionary analysis applied by PTAB panels before the issuance of the memorandum.

...

Read More

IP Newsflash

March 3, 2025

A District of Delaware judge recently granted a defendant’s motion to include a patent prosecution bar in its proposed protective order after determining that litigation counsel’s ability to practice before the Patent Office—without ever having represented the plaintiffs at the Patent Office in the past—weighed heavily in favor of the bar.

...

Read More

IP Newsflash

February 12, 2025

The Federal Circuit recently reversed a district court decision that found a patent that did not describe after-arising technology failed to satisfy the written description requirement. In so doing, the Federal Circuit explained that written description and enablement are evaluated based on the subject matter that is claimed, not the products that practice those claims. As a result, the patentee was not required to describe unclaimed, later-discovered features of the accused products despite the broad language in the claims that undisputedly covered the products.

...

Read More

IP Newsflash

January 24, 2025

The District of Delaware recently rejected a patentee’s argument that non-production of an opinion letter from counsel, combined with knowledge of the patent, warranted a finding that defendant induced infringement.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.